• course Info
  • Content
  • Ce Approvals

OMG[LP-1s] -- Eating Disorders and the Rise of Glucagon-Like Peptide-1 Receptor Agonists

CE Hours 1.75

About this course

Medication names such as Ozempic and Wegovy have become ubiquitous in the public, professional, and medical zeitgeist. These Glucagon-Like Peptide-1 Receptor Agonists (GLP-1As) and their use have generated myriad emotions, including excitement, concern, worry and outrage in American society. Join us as we discuss what GLP-1s are, why they are generating so much interest, and what they are being prescribed for across the nation. Develop an understanding of the benefits of these medications, particularly for those with Type II Diabetes Mellitus, while also considering the risks of perpetuating weight stigma, disordered eating, and eating disorders in people of all ages. We'll also discuss the recommended approaches when people with active eating disorders are prescribed these medications, whether for Type II Diabetes or weight loss / management.

Learning Objectives

  • Compare and contrast the use of GLP-1 RAs for treating diabetes and for weight management.
  • Develop the capacity to articulate how GLP-1 RAs cause weight reduction, as well as the costs and benefitsof taking GLP-1 RAs.
  • Describe three different ways the rise of of GLP-1 RAs is negatively impacting weight neutrality efforts and contributing to the risk of eating disorder development.
  • Apply recommended approaches when working with clients who have disordered eating or clinical eating disorders and are taking (or considering taking) GLP-1 RAs for weight loss.

Learning Levels

  • All Levels

Target Audience

This educational program is designed for mental health professionals, dietitians, social workers, and health care providers.

Course Instructor(s)

  • Stacy Schilter Pisano LMFT, CEDS-S

    Stacy Schilter Pisano is a Licensed Marriage and Family Therapist and Certified Eating Disorder Specialist with nearly two decades of experience supporting individuals and families affected by body dissatisfaction and eating disorders. A passionate advocate for weight-inclusive care, Stacy is committed to educating others, reducing size discrimination, and supporting individuals in divesting from diet culture. Since 2014, she has served as the director of The Emily Program's South Sound location in Olympia, Washington, overseeing a multidisciplinary team offering PHP, IOP, OP, and FBT services. Stacy also co-developed and supervises Accanto's CARE IOP, a virtual program for Binge Eating Disorder in Minnesota, Washington, and Ohio.

  • M. Hilmar Wagner, MPH, RDN, LN, CD

    Hilmar Wagner is a Registered Dietitian/Nutritionist (RDN), licensed in Minnesota and Washington State. Hilmar has experience working in a variety of clinical, outpatient, community, and management settings. Hilmar joined The Emily Program in 2006 and has served in a number of clinical and management roles, both at the site, regional and organization-wide levels. He currently serves as a Clinical Outreach Specialist. In this role Hilmar has presents on a wide range of eating disorder and related nutrition topics at local, regional, and national conferences. Hilmar received his bachelor’s degree in Nutrition/Dietetics and Master’s in Public Health Nutrition from the University of Minnesota. He has worked in the field of eating disorders for the past 17 years. Hilmar has extensive experience working with clients of all eating disorder diagnoses in both individual and group settings. He has a particular interest in the application of mindfulness and body-centered, somatic approaches to the nutritional treatment of eating disorders.

Disclosure

This educational program is made available to the public free of charge through the financial support of The Emily Program Foundation.